LATEST ARTICLES
Roche announces details of its ‘pivotal’ huntingtin-lowering study
The GENERATION-HD1 trial will test whether RG6042 – formerly Ionis-HTTRx – slows the progression of Huntington's disease
t’s a time of huge developments in the...
New £9.1m contract with a top 10 global pharmaceutical company
Specialist medical imaging services for a Phase III Huntington’s disease clinical trial, highlighting the value of IXICO’s data science expertise in neuroscience drug development.
IXICO...
Predict the onset and course of Huntington’s disease
The origin of this incurable nervous disease lies in minute fibers formed by chains of the huntingtin protein
MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE IN...
UNIVERSITY
Study Suggests Potential Therapy for Huntington’s Disease
A new study published in the Proceedings of the National Academy of Sciences (PNAS) suggests that Huntington’s disease may take effect much earlier in life than...
New insight into Huntington’s disease may open door to drug development
Researchers have developed a new theory on Huntington’s disease which is being welcomed for showing promise to open new avenues of drug development for...
Scientists develop new approach to understand Huntington’s
Neurological diseases are typically associated with a multitude of molecular changes. But out of these thousands of changes in gene expression, which ones are...
Researchers find important new piece in the Huntington’s disease puzzle
HUNTINGTON'S DISEASE
In a new study, researchers from the University of Copenhagen have discovered a hitherto unknown error in the transport of glutamine between astrocytes...
HDBUZZ
Roche announces details of its ‘pivotal’ huntingtin-lowering study
The GENERATION-HD1 trial will test whether RG6042 – formerly Ionis-HTTRx – slows the progression of Huntington's disease
t’s a time of huge developments in the...
Disappointing news from LEGATO-HD trial of laquinimod in Huntington’s disease
The LEGATO-HD trial of laquinimod did not slow progression of Huntington's disease. Here's the lowdown.
The LEGATO-HD trial of laquinimod to slow progression of Huntington’s...
ARTICLES
IONIS-HTTRx
